-
1
-
-
0025239384
-
Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline by complementary DNA-expressed human liver P-450
-
AOYAMA, T., GELBOIN, H. V., and GONZALEZ, F. J., 1990, Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline by complementary DNA-expressed human liver P-450. Cancer Research, 50, 2060-2063.
-
(1990)
Cancer Research
, vol.50
, pp. 2060-2063
-
-
Aoyama, T.1
Gelboin, H.V.2
Gonzalez, F.J.3
-
3
-
-
0024336157
-
Urinary metabolites of rifabutin, a new antimycobacterial agent, in human volunteers
-
COCCHIARA, G., STOROLIN BENEDETTI, M., VICARIO, G. P., BALLABIO, M., GIOIA, B., VIOGLIO, S., and VIGEVANI, A., 1989, Urinary metabolites of rifabutin, a new antimycobacterial agent, in human volunteers. Xenobiotica, 19, 769-780.
-
(1989)
Xenobiotica
, vol.19
, pp. 769-780
-
-
Cocchiara, G.1
Storolin Benedetti, M.2
Vicario, G.P.3
Ballabio, M.4
Gioia, B.5
Vioglio, S.6
Vigevani, A.7
-
4
-
-
0025179176
-
Human cytochrome P450IIA3: CDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1
-
CRESPI, C. L., PENMAN, B. W., LEAKEY, J. A. E., ARLOTTO, M. P., STARK, A., PARKINSON, A., TURNER, T., STEIMEL, D. T., RUDO, K., DAVIES, R. L., and LANGENBACH, R., 1990, Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis, 11, 1293-1300.
-
(1990)
Carcinogenesis
, vol.11
, pp. 1293-1300
-
-
Crespi, C.L.1
Penman, B.W.2
Leakey, J.A.E.3
Arlotto, M.P.4
Stark, A.5
Parkinson, A.6
Turner, T.7
Steimel, D.T.8
Rudo, K.9
Davies, R.L.10
Langenbach, R.11
-
5
-
-
0025949636
-
Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: Evidence for species-specific metabolism
-
CZERWINSKI, M., MCLEMORE, T. L., PHILPOT, R. M., NHAMBURO, P. T., KORZEKWA, K., GELBOIN, H. V., and GONZALEZ, F. J., 1991, Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: evidence for species-specific metabolism. Cancer Research, 51, 4636-4638.
-
(1991)
Cancer Research
, vol.51
, pp. 4636-4638
-
-
Czerwinski, M.1
Mclemore, T.L.2
Philpot, R.M.3
Nhamburo, P.T.4
Korzekwa, K.5
Gelboin, H.D.6
Gonzalez, F.J.7
-
6
-
-
0027275495
-
A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates
-
DONATO, M. T., GOMEZ-LECHON, M. J., and CASTELL, J. V., 1993, A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates. Analytical Biochemistry, 213, 29-33.
-
(1993)
Analytical Biochemistry
, vol.213
, pp. 29-33
-
-
Donato, M.T.1
Gomez-Lechon, M.J.2
Castell, J.V.3
-
7
-
-
0027537219
-
Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits
-
EMORI, M., SAITO, H., SATO, K., TOMIOKA, H., SETOGAWA, T., and HIDAKA, T., 1993, Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits. Antimicrobial Agents and Chemotherapy, 37, 722-728.
-
(1993)
Antimicrobial Agents and Chemotherapy
, vol.37
, pp. 722-728
-
-
Emori, M.1
Saito, H.2
Sato, K.3
Tomioka, H.4
Setogawa, T.5
Hidaka, T.6
-
8
-
-
0028352117
-
In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives
-
FUJII, K., TSUJI, A., MIYAZAKI, S., YAMAGUCHI, K., and GOTO, S., 1994, In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives. Antimicrobial Agents and Chemotherapy, 38, 1118-1122.
-
(1994)
Antimicrobial Agents and Chemotherapy
, vol.38
, pp. 1118-1122
-
-
Fujii, K.1
Tsuji, A.2
Miyazaki, S.3
Yamaguchi, K.4
Goto, S.5
-
9
-
-
0028987873
-
Cytochromes P450 expression systems
-
GONZALEZ, F. J., and KORZEKWA, K. R., 1995, Cytochromes P450 expression systems. Annual Review of Pharmacology and Toxicology, 35, 369-390.
-
(1995)
Annual Review of Pharmacology and Toxicology
, vol.35
, pp. 369-390
-
-
Gonzalez, F.J.1
Korzekwa, K.R.2
-
10
-
-
0028209357
-
High-performance liquid chromatographic determination of 3′-hydroxy-5′-(4-isobutyl-1-piperazinyl)-benzoxazinorifamycin (KRM-1648) and its deacetyl metabolite in plasma, whole blood, urine and tissue samples in rats
-
HOSOE, K., KONISHI, E., HIDAKA, T., YAMANE, T., YAMASHITA, K., and OHASHI, T., 1994, High-performance liquid chromatographic determination of 3′-hydroxy-5′-(4-isobutyl-1-piperazinyl)-benzoxazinorifamycin (KRM-1648) and its deacetyl metabolite in plasma, whole blood, urine and tissue samples in rats. Journal of Chromatography B, 653, 177-186.
-
(1994)
Journal of Chromatography B
, vol.653
, pp. 177-186
-
-
Hosoe, K.1
Konishi, E.2
Hidaka, T.3
Yamane, T.4
Yamashita, K.5
Ohashi, T.6
-
11
-
-
0029872462
-
Identification and antimicrobial activity of urinary metabolites of a rifamycin derivative in dog
-
HOSOE, K., MAE, T., YAMASHITA, K., FUJII, K., YAMANE, T., HIDAKA, T., and OHASHI, T., 1996, Identification and antimicrobial activity of urinary metabolites of a rifamycin derivative in dog. Xenobiotica 26, 321-332.
-
(1996)
Xenobiotica
, vol.26
, pp. 321-332
-
-
Hosoe, K.1
Mae, T.2
Yamashita, K.3
Fujii, K.4
Yamane, T.5
Hidaka, T.6
Ohashi, T.7
-
12
-
-
0013958297
-
Evidence for biochemically different types of vesicles in the hepatic microsomal fraction
-
IMAI, Y., ITO, A., and SATO, R., 1966, Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. Journal of Biochemistry, 60, 417-428.
-
(1966)
Journal of Biochemistry
, vol.60
, pp. 417-428
-
-
Imai, Y.1
Ito, A.2
Sato, R.3
-
13
-
-
0024311986
-
Expression of four phenobarbital-inducible cytochrome P-450s in liver, kidney, and lung of rats
-
IMAOKA, S., TERANO, Y., and FUNAE, Y., 1989, Expression of four phenobarbital-inducible cytochrome P-450s in liver, kidney, and lung of rats. Journal of Biochemistry, 105, 939-945.
-
(1989)
Journal of Biochemistry
, vol.105
, pp. 939-945
-
-
Imaoka, S.1
Terano, Y.2
Funae, Y.3
-
14
-
-
0028114141
-
Activity of the benzoxazinorifamycin KRM-1648 against the Mycobacterium avium complex in vitro and in macrophages
-
INDERLIED, C. B., BARBARA-BURNHAM, L., WU, M., YOUNG, L., and BERMUDEZ, L., 1994, Activity of the benzoxazinorifamycin KRM-1648 against the Mycobacterium avium complex in vitro and in macrophages. Antimicrobial Agents and Chemotherapy, 38, 1838-1843.
-
(1994)
Antimicrobial Agents and Chemotherapy
, vol.38
, pp. 1838-1843
-
-
Inderlied, C.B.1
Barbara-Burnham, L.2
Wu, M.3
Young, L.4
Bermudez, L.5
-
15
-
-
0028093427
-
Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model
-
KLEMENS, S. P., GROSSI, M. A., and CYNAMON, M. H., 1994, Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model. Antimicrobial Agents and Chemotherapy, 38, 2245-2248.
-
(1994)
Antimicrobial Agents and Chemotherapy
, vol.38
, pp. 2245-2248
-
-
Klemens, S.P.1
Grossi, M.A.2
Cynamon, M.H.3
-
16
-
-
0025977668
-
In vitro activities of new rifamycin derivatives against mycobacteria
-
KUZE, F., YAMAMOTO, T., AMITANI, R., and SUZUKI, K., 1991, In vitro activities of new rifamycin derivatives against mycobacteria. Kekkaku, 66, 7-12.
-
(1991)
Kekkaku
, vol.66
, pp. 7-12
-
-
Kuze, F.1
Yamamoto, T.2
Amitani, R.3
Suzuki, K.4
-
17
-
-
0028835430
-
In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli
-
LUNA-HERRERA, J., REDDY, M. V., and GANGADHARAM, P. R. J., 1995, In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli. Antimicrobial Agents and Chemotherapy, 39, 440-444.
-
(1995)
Antimicrobial Agents and Chemotherapy
, vol.39
, pp. 440-444
-
-
Luna-Herrera, J.1
Reddy, M.V.2
Gangadharam, P.R.J.3
-
18
-
-
9044254525
-
P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
-
NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN, J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, O., COON, M. J., ESTABROOK, R. W., GUNSALUS, I. C., and NERBERT, D. W., 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1-42.
-
(1996)
Pharmacogenetics
, vol.6
, pp. 1-42
-
-
Nelson, D.R.1
Koymans, L.2
Kamataki, T.3
Stegeman, J.J.4
Feyereisen, R.5
Waxman, D.J.6
Waterman, M.R.7
Gotoh, O.8
Coon, M.J.9
Estabrook, R.W.10
Gunsalus, I.C.11
Nerbert, D.W.12
-
19
-
-
50449100139
-
The carbon monoxide-binding pigment of liver microsomes
-
OMURA, T., and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry, 239, 2379-2385.
-
(1964)
Journal of Biological Chemistry
, vol.239
, pp. 2379-2385
-
-
Omura, T.1
Sato, R.2
-
20
-
-
0026034493
-
In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins
-
SAITO, H., TOMIOKA, H., SATO, K., EMORI, M., YAMANE, T., YAMASHITA, K., HOSOE, K., and HIDAKA, T., 1991, In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins. Antimicrobial Agents and Chemotherapy, 35, 542-547.
-
(1991)
Antimicrobial Agents and Chemotherapy
, vol.35
, pp. 542-547
-
-
Saito, H.1
Tomioka, H.2
Sato, K.3
Emori, M.4
Yamane, T.5
Yamashita, K.6
Hosoe, K.7
Hidaka, T.8
-
21
-
-
0028237729
-
Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
-
SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y., and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414-423.
-
(1994)
Journal of Pharmacology and Experimental Therapeutics
, vol.270
, pp. 414-423
-
-
Shimada, T.1
Yamazaki, H.2
Mimura, M.3
Inui, Y.4
Guengerich, F.P.5
-
22
-
-
9544252621
-
Use of human P450 expression system in studies of xenobiotic metabolism
-
TAINAKA, H., HATANAKA, T., and ONO, S., 1995, Use of human P450 expression system in studies of xenobiotic metabolism. Xenobiotic Metabolism and Disposition, 10, 420-425.
-
(1995)
Xenobiotic Metabolism and Disposition
, vol.10
, pp. 420-425
-
-
Tainaka, H.1
Hatanaka, T.2
Ono, S.3
-
23
-
-
0026515252
-
Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice
-
TOMIOKA, H., SAITO, H., SATO, K., YAMANE, T., YAMASHITA, K., HOSOE, K., FUJII, K., and HIDAKA, T., 1992, Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice. Antimicrobial Agents and Chemotherapy, 36, 387-393.
-
(1992)
Antimicrobial Agents and Chemotherapy
, vol.36
, pp. 387-393
-
-
Tomioka, H.1
Saito, H.2
Sato, K.3
Yamane, T.4
Yamashita, K.5
Hosoe, K.6
Fujii, K.7
Hidaka, T.8
-
24
-
-
0022349049
-
Identification of urinary metabolites of rifamycin LM 427 in man
-
VIGEVANI, A., BALLABIO, M., GIOIA, B., MARSILI, L., VIOGLIO, S., and FRANCESCHI, G., 1985, Identification of urinary metabolites of rifamycin LM 427 in man. Journal of Antibiotics, 38, 1799-1802.
-
(1985)
Journal of Antibiotics
, vol.38
, pp. 1799-1802
-
-
Vigevani, A.1
Ballabio, M.2
Gioia, B.3
Marsili, L.4
Vioglio, S.5
Franceschi, G.6
-
25
-
-
0025634037
-
In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex
-
YAMAMOTO, T., AMITANI, R., KUZE, F., and SUZUKI, K., 1990, In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex. Kekkaku, 65, 805-810.
-
(1990)
Kekkaku
, vol.65
, pp. 805-810
-
-
Yamamoto, T.1
Amitani, R.2
Kuze, F.3
Suzuki, K.4
-
26
-
-
0027479998
-
Synthesis and biological activity of 3′-hydroxy-5′-aminobenzoxazinorifamycin derivatives
-
YAMANE, T., HASHIZUME, T., YAMASHITA, K., KONISHI, E., HOSOE, K., HIDAKA, T., WATANABE, K., KAWAHARADA, H., YAMAMOTO, T., and KUZE, F., 1993, Synthesis and biological activity of 3′-hydroxy-5′-aminobenzoxazinorifamycin derivatives. Chemical and Pharmaceutical Bulletin, 41, 148-155.
-
(1993)
Chemical and Pharmaceutical Bulletin
, vol.41
, pp. 148-155
-
-
Yamane, T.1
Hashizume, T.2
Yamashita, K.3
Konishi, E.4
Hosoe, K.5
Hidaka, T.6
Watanabe, K.7
Kawaharada, H.8
Yamamoto, T.9
Kuze, F.10
|